However, the study group did not represent the general population as the study sample was a mix of 44 children clinically suspected of CeD and 48 children diagnosed during the screening of genetically susceptible individuals monitored prospectively for the development of type 1 diabetes-associated autoantibodies and TTG-IgA. The gene discussed is CD79A; the disease is type 1 diabetes mellitus.